GlassScriptPhysician profile
Ryan Tarr
NPI 1659786697
$19,312.17
in general payments reported to CMS, 2019-2025
13 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,755 · 2021: $1,344 · 2022: $1,628 · 2023: $1,096 · 2024: $101 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Travel and Lodging: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.20 |
| Travel and Lodging | $692.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,738.80 | 2019-2023 | Distal Extremities Implants Soft Tissue Anchors, Distal Extremities Implants Trauma Distal Radius |
| Cdc Medical LLC | $2,342.00 | 2019 | |
| Tricoast Surgical Solutions LLC | $1,762.41 | 2022-2023 | |
| Liberty Surgical INC. | $1,397.00 | 2020 | |
| Southtech Orthopedics | $1,200.00 | 2021 | |
| Acumed LLC | $772.14 | 2019-2024 | Acumed, Innate Implant |
| Endo Pharmaceuticals INC. | $423.87 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $394.55 | 2024-2025 | Xiaflex |
| Stryker Corporation | $109.92 | 2025 | Aequalis Perform Reversed, Gamma |
| Collegium Pharmaceutical, INC. | $74.36 | 2021 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.67 | 2021 | |
| Redhill Biopharma INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Tarr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.